Inositol trisphosphate and activators of protein kinase C modulate membrane currents in tail motor neurons of Aplysia.
1. We have investigated how activation of the inositol lipid second messenger pathway may contribute to modulation of membrane currents in tail motor neurons of Aplysia. Specifically, we examined the effects of injected inositol 1,4,5-trisphosphate (IP3) and analogues of diacylglycerol (DAG), both of which are products of the hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2). 2. Injection of IP3 produced an outward current associated with an apparent increase in membrane conductance. Ion substitution experiments, the sensitivity of the response to low concentrations of TEA and its attenuation by intracellular injections of EGTA suggest that the current produced by injection of IP3 is a calcium-activated K+ current (IK,Ca). 3. The response to IP3 was mimicked by intracellular injection of Ca2+. Injection of Ca2+ produced an outward current that was associated with an apparent increase in input conductance of the membrane. The same manipulations that affected the response to IP3 (see above) also affected the response to injections of Ca2+. 4. Injections of activators of protein kinase C (PKC) produced a relatively slow inward current. The inward current has not been fully analyzed, but it does not appear to be due to the actions of any single conventional ion channel. 5. Activators of PKC attenuated responses to subsequent injections of IP3 indicating that one component of PIP2 hydrolysis can attenuate the other. 6. The results suggest that hydrolysis of inositol phospholipids is a mechanism for regulation of membrane properties in tail motor neurons of Aplysia.
Department of Neurobiology and Anatomy, University of Texas Medical School, Houston 77225.
M
M
Sawada
L J
LJ
Cleary
J H
JH
Byrne
D000818:Animals; D001048:Aplysia; D001696:Biomechanical Phenomena; D002118:Calcium / Q000502:physiology; D004075:Diglycerides / Q000494:pharmacology*; D004594:Electrophysiology; D004789:Enzyme Activation; D005989:Glycerides / Q000494:pharmacology*; D015544:Inositol 1,4,5-Trisphosphate; D007295:Inositol Phosphates / Q000494:pharmacology*; D007477:Ions; D009046:Motor Neurons / Q000502:physiology*; D015240:Phorbol 12,13-Dibutyrate / Q000494:pharmacology; D011493:Protein Kinase C / Q000378:metabolism*; D013403:Sugar Phosphates / Q000494:pharmacology*; D013623:Tail
D004075:Diglycerides; D005989:Glycerides; D007295:Inositol Phosphates; D007477:Ions; D013403:Sugar Phosphates; D015240:Phorbol 12,13-Dibutyrate; D015544:Inositol 1,4,5-Trisphosphate; C038237:1-oleoyl-2-acetylglycerol; D011493:Protein Kinase C; D002118:Calcium